Equity Incentive Plan (Details) - USD ($)						3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 22, 2022	Jun. 03, 2022	Apr. 04, 2022	Mar. 14, 2022	Jan. 06, 2022	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Jul. 20, 2021
Equity Incentive Plan (Details) [Line Items]
RSUs grant (in Shares)	27,854	40,000
RSU per share (in Dollars per share)	$ 6.1	$ 8.73
Employment agreements description			the Company appointed K. Chris Min, M.D., Ph.D. as its Chief Medical Officer. Dr. Min’s employment agreement provides annual base salary of $350,000, and he will be eligible to receive a performance bonus equal to 30% of his base salary, prorated for his first year of employment. Dr. Min received a $60,000 signing bonus, with 50% of this amount paid in RSUs and 50% in stock options. Dr. Min also received two equity incentive awards; 150,000 RSUs and a stock option award exercisable for 50,000 shares. Each award will vest 25% upon the first-year anniversary of his first day of employment with Longeveron, with 25% vesting thereafter on the second, third and fourth anniversaries of his employment. In each case, the vesting of the equity awards will be subject to Dr. Min’s continued service through the applicable vesting dates. RSUs shall be expensed on a quarterly basis at the rate of $0.1 million for the quarterly vesting amount of 9,375 RSUs, with a price per share of $12.85 (the closing price of the Company’s stock on April 4, 2022). Stock options shall be expensed based upon a Black-Scholes calculation, the price per share to be expensed was $11.34 and a total cost of $0.6 million would be expensed ratably over 48 months.
Cash						$ 20,200,000		$ 20,200,000
Fair market value per share (in Dollars per share)											$ 6.08
RSUs outstanding (in Shares)								302,046		196,751
Outstanding common stock shares								5.00%
Dividend yield								0.00%
Expected life								10 years
Volatility								95.00%
Issued and outstanding options (in Shares)						415,473		415,473
Weighted average exercise price (in Dollars per share)						$ 9.21		$ 9.21		$ 5.96
Stock option issued and outstanding (in Shares)								304,449
Exercise price per share (in Dollars per share)						$ 5.96		$ 5.96
Granted awards (in Shares)		5,000		22,000	84,825
Exercise price (in Dollars per share)		$ 8.73		$ 5.94	$ 10
Calculation price (in Dollars per share)		$ 7.73		$ 5.23	$ 8.78
Total cost		$ 100,000		$ 100,000	$ 700,000
Vesting period				25.00%	25.00%
Expensed ratably over				48 months	48 months
Equity based compensation expense						$ 900,000	$ 2,200,000	$ 1,400,000	$ 3,500,000
Unrecognized equity based compensation								$ 3,500,000
Maturity term								3 years 9 months
Minimum [Member]
Equity Incentive Plan (Details) [Line Items]
Risk-free interest rate								1.23%
Maximum [Member]
Equity Incentive Plan (Details) [Line Items]
Risk-free interest rate								2.14%
Series C [Member]
Equity Incentive Plan (Details) [Line Items]
Granted amount	$ 170,000
Mr. Green [Member]
Equity Incentive Plan (Details) [Line Items]
Bonus for the completion											$ 100,000
Mr. Green [Member] | Restricted Stock Units (RSUs) [Member]
Equity Incentive Plan (Details) [Line Items]
Cash						8,223		$ 8,223
Mr. Lehr [Member]
Equity Incentive Plan (Details) [Line Items]
Bonus for the completion											75,000
Mr. Lehr [Member] | Restricted Stock Units (RSUs) [Member]
Equity Incentive Plan (Details) [Line Items]
Cash						6,167		6,167
Dr. Hare [Member]
Equity Incentive Plan (Details) [Line Items]
Bonus for the completion											$ 75,000
Dr. Hare [Member] | Restricted Stock Units (RSUs) [Member]
Equity Incentive Plan (Details) [Line Items]
Cash						$ 12,335		$ 12,335